Aesthetic Medical International Announces Change of Auditor and Change of Director
December 12 2023 - 6:45PM
Aesthetic Medical International Holdings Group Limited (Nasdaq:
AIH) (the “Company” or “AIH”), a leading provider of aesthetic
medical services in China, announced (1) the appointment of Onestop
Assurance PAC as the Company’s independent registered public
accounting firm to replace Union Power HK CPA Limited (“Union
Power”), effective December 12, 2023; (2) the resignation of Mr.
JIM Wai Hang from his position as an independent director and a
member of the audit committee of the board of directors of the
Company (the“Board”), due to personal reasons, with effect on and
from December 12, 2023; and (3) the appointment of Ms. XU Tianqing
as an independent director and a member of the audit committee of
the Board, with effect on and from December 12, 2023.
Change of Auditor
The change of the Company’s independent
registered public accounting firm was made after careful
consideration and evaluation process and was approved by the audit
committee and the Board.
The audit reports of Union Power on the
consolidated financial statements of the Company as of and for the
fiscal years ended December 31, 2021 and 2022 did not contain any
adverse opinion or disclaimer of opinion, nor were they qualified
or modified as to uncertainty, audit scope, or accounting
principles. During the fiscal years ended December 31, 2021 and
2022 and through the subsequent interim to date, there were no
disagreements between the Company and Union Power on any matter of
accounting principles or practices, financial statement disclosure,
or auditing scope or procedures, which, if not resolved to Union
Power’s satisfaction, would have caused Union Power to make
reference thereto in their report on the financial statements for
such years.
Union Power has confirmed that there are no
matters relating to their retirement that need to be brought to the
attention of the shareholders of the Company. The Board has also
confirmed that the Company has no disagreement or unresolved
matters with Union Power, and is not aware of any matters that need
to be brought to the attention of the shareholders of the
Company.
Change of Director
Mr. JIM Wai Hang resigned from the Board, effective on and from
December 12, 2023. Mr. JIM Wai Hang resigned for personal reasons
and not due to any disagreement with the Company on any matter
relating to the Company's operations, policies, or practices. Mr.
JIM Wai Hang has confirmed that he has no disagreement with the
Board and there is no other matter relating to his resignation as
an independent director that needs to be brought to the attention
of the shareholders of the Company or the Nasdaq.
Ms. XU Tianqing was appointed as an independent director and a
member of the audit committee of the Board, effective on and from
December 12, 2023. The biographical details of Ms. XU Tianqing are
set out below.
Ms. XU Tianqing has over 5 years of experience in the financial
services industry across principal investment and investment
banking, currently covering the Greater China Region for ADV
Partners. Prior to joining ADV, Ms. XU Tianqing worked at Barclays
Capital’s investment banking division from 2018 to 2021. Ms. XU
Tianqing holds a dual bachelor’s degree in Molecular & Cell
Biology and Economics from the University of California,
Berkeley.
About Aesthetic Medical International Holdings Group
Limited
AIH, known as “Peng’ai” in China, is a leading
provider of aesthetic medical services in China. AIH operates
through treatment centers that are spread across major cities in
mainland China, with a major focus on the Guangdong-Hong Kong-Macau
Greater Bay area and the Yangtze River Delta area. Leveraging over
20 years of clinical experience, AIH provides one-stop aesthetic
service offerings, including surgical aesthetic treatments,
non-surgical aesthetic treatments, general medical services, and
other aesthetic services. For more information regarding the
Company, please visit https://ir.aihgroup.net/.
Cautionary Statements
This press release contains “forward-looking
statements.” These statements are made under the “safe harbor”
provisions of the U.S. Private Securities Litigation Reform Act of
1995. These forward-looking statements can be identified by
terminology such as “will”, “expects”, “anticipates”, “aims”,
“future”, “intends”, “plans”, “believes”, “estimates”, “likely to”
and similar statements. Statements that are not historical facts,
including statements about the Company’s beliefs, plans and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties. These risks
and uncertainties and others that relate to the Company’s business
and financial condition are detailed from time to time in the
Company’s SEC filings, and could cause the actual results to differ
materially from those contained in any forward-looking statement.
These forward-looking statements are made only as of the date
indicated, and the Company undertakes no obligation to update or
revise the information contained in any forward-looking statements,
except as required under applicable law.
Investor Relations Contacts
For investor and media inquiries, please
contact:Aesthetic Medical International Holdings Group
LimitedEmail: ir@pengai.com.cnWebsite:
https://ir.aihgroup.net
Aesthetic Medical (NASDAQ:AIH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aesthetic Medical (NASDAQ:AIH)
Historical Stock Chart
From Sep 2023 to Sep 2024